Références
(1) Amdur MO, Doull J, Klaassen CD. Casarett and Doull's toxicology: the basic science of poisons. 4th ed. 1991.
(2) Lacour M, Zunder T, Schmidtke K, Vaith P, Scheidt C. Multiple chemical sensitivity syndrome (MCS)--suggestions for an extension of the U.S. MCS-case definition. Int J Hyg Environ Health. 2005;208:141-151.
(3) Miller CS. The Compelling Anomaly of Chemical Intolerance. Annals of the New York Academy of Sciences. 2001;933:1-23.
(4) Multiple chemical sensitivity: a 1999 consensus. Arch Environ Health. 1999;54:147-149.
(5) McKeown-Eyssen GE, Baines CJ, Marshall LM, Jazmaji V, Sokoloff ER. Multiple chemical sensitivity: discriminant validity of case definitions. Arch Environ Health. 2001;56:406-412.
(6) Johansson O. Electrohypersensitivity: State-of-the-Art of a Functional Impairment. Electromagn Biol Med. 2006;25:245-258.
(7) Bailey WH. Health effects relevant to the setting of EMF exposure limits. Health Phys. 2002;83:376-386.
(8) Havas M. Electromagnetic hypersensitivity: biological effects of dirty electricity with emphasis on diabetes and multiple sclerosis. Electromagn Biol Med. 2006;25:259-268.
(9) Park J and Knudson S. Medically unexplained physical symptoms. Statistics Canada . 12-1-2007.
(10) Statistics Canada, Health Statistics Division. How healthy are Canadians? Health Reports - Supplement to Volume 16 catalogue no. 820003-XPE. 2006. Canadian Institute for Health Information. Health Reports.
(11) Statistics Canada. Findings from the 2005 National Survey of the Work and Health of Nurses. Statistics Canada . 11-12-2006.
(12) Caress SM, Steinemann AC. A review of a two-phase population study of multiple chemical sensitivities. Environ Health Perspect. 2003;111:1490-1497.
(13) Kreutzer R, Neutra RR, Lashuay N. Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am J Epidemiol. 1999;150:1-12.
(14) Caress SM, Steinemann AC. National prevalence of asthma and chemical hypersensitivity: an examination of potential overlap. J Occup Environ Med. 2005;47:518-522.
(15) Meggs WJ, Dunn KA, Bloch RM, Goodman PE, Davidoff AL. Prevalence and nature of allergy and chemical sensitivity in a general population. Arch Environ Health. 1996;51:275-282.
(16) McKeown-Eyssen G, Baines C, Cole DE et al. Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR. Int J Epidemiol. 2004;33:971-978.
(17) Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers. 2003;8:1-12.
(18) Furlong CE, Cole TB, Jarvik GP et al. Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants. Neurotoxicology. 2005;26:651-659.
(19) Cole TB, Jampsa RL, Walter BJ et al. Expression of human paraoxonase (PON1) during development. Pharmacogenetics. 2003;13:357-364.
(20) Haley RW, Billecke S, La Du BN. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol. 1999;157:227-233.
(21) La Du BN, Billecke S, Hsu C, Haley RW, Broomfield CA. Serum paraoxonase (PON1) isozymes: the quantitative analysis of isozymes affecting individual sensitivity to environmental chemicals. Drug Metab Dispos. 2001;29:566-569.
(22) Schnakenberg E, Fabig KR, Stanulla M et al. A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug metabolizing enzymes. Environ Health. 2007;6:6.
(23) Baines CJ, McKeown-Eyssen GE, Riley N et al. Case-control study of multiple chemical sensitivity, comparing haematology, biochemistry, vitamins and serum volatile organic compound measures. Occup Med (Lond). 2004;54:408-418.
(24) Miller CS, Gammage RB, Jankovic JT. Exacerbation of chemical sensitivity: a case study. Toxicol Ind Health. 1999;15:398-402.
(25) Brasche S, Bullinger M, Morfeld M, Gebhardt HJ, Bischof W. Why do women suffer from sick building syndrome more often than men?--subjective higher sensitivity versus objective causes. Indoor Air. 2001;11:217-222.
(26) McKeown-Eyssen GE, Sokoloff ER, Jazmaji V, Marshall LM, Baines CJ. Reproducibility of the University of Toronto self-administered questionnaire used to assess environmental sensitivity. Am J Epidemiol. 2000;151:1216-1222.
(27) Joffres MR, Williams T, Sabo B, Fox RA. Environmental sensitivities: prevalence of major symptoms in a referral center: the Nova Scotia Environmental Sensitivities Research Center Study. Environ Health Perspect. 2001;109:161-165.
(28) Gibson PR, Elms AN, Ruding LA. Perceived treatment efficacy for conventional and alternative therapies reported by persons with multiple chemical sensitivity. Environ Health Perspect. 2003;111:1498-1504.
(29) Caress SM, Steinemann AC, Waddick C. Symptomatology and etiology of multiple chemical sensitivities in the southeastern United States. Arch Environ Health. 2002;57:429-436.
(30) Caress SM, Steinemann AC. Prevalence of multiple chemical sensitivities: a population-based study in the southeastern United States. Am J Public Health. 2004;94:746-747.
(31) Shannon M, Woolf A, Goldman R. Children's environmental health: one year in a pediatric environmental health specialty unit. Ambul Pediatr. 2003;3:53-56.
(32) Woolf A. A 4-year-old girl with manifestations of multiple chemical sensitivities. Environ Health Perspect. 2000;108:1219-1223.
(33) Bornehag CG, Sundell J, Hagerhed-Engman L, Sigsggard T, Janson S, Aberg N. 'Dampness' at home and its association with airway, nose, and skin symptoms among 10,851 preschool children in Sweden: a cross-sectional study. Indoor Air. 2005;15:48-55.
(34) Savilahti R, Uitti J, Laippala P, Husman T, Roto P. Respiratory morbidity among children following renovation of a water-damaged school. Arch Environ Health. 2000;55:405-410.
(35) Guillette EA. A broad-based evaluation of pesticide-exposed children. Cent Eur J Public Health. 2000;8 Suppl:58-9.:58-59.
(36) Meklin T, Potus T, Pekkanen J, Hyvarinen A, Hirvonen MR, Nevalainen A. Effects of moisture-damage repairs on microbial exposure and symptoms in schoolchildren. Indoor Air. 2005;15 Suppl 10:40-7.:40-47.
(37) Menzies IC. Disturbed children: the role of food and chemical sensitivities. Nutr Health. 1984;3:39-54.
(38) Grandjean P, Harari R, Barr DB, Debes F. Pesticide exposure and stunting as independent predictors of neurobehavioral deficits in Ecuadorian school children. Pediatrics. 2006;117:e546-e556.
(39) Grandjean P, Landrigan JP. Developmental neurotoxicity of industrial chemicals. The Lancet. 2006;DOI:10.1016/S0140-6736(06)69665-7.
(40) Bell IR, Schwartz GE, Peterson JM, Amend D. Self-reported illness from chemical odors in young adults without clinical syndromes or occupational exposures. Arch Environ Health. 1993;48:6-13.
(41) Huss A, Roosli M. Consultations in primary care for symptoms attributed to electromagnetic fields--a survey among general practitioners. BMC Public Health. 2006;6:267.:267.
(42) Mild KH, Repacholi M, van Deventer E, and Ravanzzani P. Proceedings, International Workshop on EMF Hypersensitivity, Prague, Czech Republic, October 25-27, 2004. 2006.
(43) International Commission for Electromagnetic Safety (ICEMS). Benevento Resolution. International Commission for Electromagnetic Safety (ICEMS) . 2006.
(44) European Parliament Press Service. Parliament adopts REACH - new EU chemicals legislation and new chemicals agency. Exp.Biol.Med.(Maywood.). 13-12-2006.
(45) Seidel HJ. Environmental medicine in Germany--a review. Environ Health Perspect. 2002;110 Suppl 1:113-8.:113-118.
(46) Danish Environmental Protection Agency and Danish Ministry of the Environment. Multiple Chemical Sensitivity, MCS, Environmental Project no. 988, 2005. Danish Environmental Protection Agency . 2005.
(47) World Health Organization. History of the development of the ICD. World Health Organization . 2006.
(48) World Health Organization. Cumulative Official Updates to ICD-10. World Health Organization . 2006.
(49) Canadian Institute for Health Information. International Statistical Classification of Diseases and Related Health Problems. Canadian Institute for Health Information . 2006.
(50) Health Canada. Environmental Sensitivities - Drugs and Health Products Newsletter. Health Canada . 2005.
(51) Canadian Health Network. What is chemical sensitivity? Canadian Health Network.Canadian Public Health Agency . 2006
(52) Pest Management Regulatory Agency, Health Canada. Proposed Acceptability for Continuing Registration. Re-evaluation of Malathion. PACR2003-10. Pest Management Regulatory Agency, Health Canada. 2003.
(53) Sears M, Walker CR, van der Jagt RHC, Claman P. Pesticide Assessment: Protecting Public Health on the Home Turf. Paediatr Child Health. 2006;11:229-234.
(54) Canadian Centre for Occupational Health and Safety. Indoor Air Quality: A Legitimate OSH Concern. Canadian Centre for Occupational Health and Safety . 2006.
(55) Byus CM, GlickmanBW, Krewski D, LotzGW, Mandeville R, McBride ML, Prato FS, and Weaver DF. A review of the Potential Health Risks of Radiofrequency Fields from Wireless Telecommunication Devices. 1999. Royal Society of Canada, for Health Canada.
(56) Krewski D, Byus CV, Glickman BW, Habash RWY, Habbick B, Lotz GW, Mandeville R, McBride ML, Prato FS, Salem T, and Weaver DF. Recent Advances in Research on Radiofrequency Fields and Health: 2001-2003
A Follow-up toThe Royal Society of Canada Report on the Potential Health Risks of Radiofrequency Fields from Wireless Telecommunication Devices, 1999 and update. Royal Society of Canada . 2004.
(57) Cunningham R. National and Subnational Legislation Requiring Enclosed Restaurants and Bars to be 100% Smoke-free. Ottawa Council on Smoking and Health . 20-7-2006.
(58) Developpement durable, Environnement et Parcs Quebec. The Pesticides Management Code. Quebec - Developpement durable,Environnement et Parcs . 2006.
(59) Santé et Services sociaux Québec. Plan d'intervention de protection de la santé publique contre le virus du Nil occidental 2006. Gouvernement du Québec, 2006 . 2006.
(60) Thomson GM, Day JH, Ewers SE, Gerrard JW, McCourtie DR, and Woodward WD. Report of the ad hoc committee on environmental sensitivities. 1985.
(61) Jones D. Nova Scotia only province to provide clinic for "environmentally sensitive" patients. CMAJ. 1992;147:931-933.
(62) WorkSafeBC Policy and Research Division. Compensation for Occupational Asthma and Contact Dermatitis Policy and Research Division Discussion Paper. Ontario Workplace Tribunals Library owtlibrary.on.ca . 2006.
(63) Christie M. Private Property Pesticide By-laws In Canada Population Statistics by Municipality. www.healthyottawa.ca . 2006. http://www.flora.org/healthyottawa/BylawList.pdf available from http://www.flora.org/healthyottawa/BylawList.pdf
(64) Canadian Medical Association. Policy resolution GC04-50 - Combined fertilizer / pesticides. 18-8-2004.
(65) Marshall L, Weir E, Abelsohn A, Sanborn MD. Identifying and managing adverse environmental health effects: 1. Taking an exposure history. CMAJ. 2002;166:1049-1055.
(66) Robb N. The environment was right for Nova Scotia's new environmental health clinic. CMAJ. 1995;152:1292-1295.
(67) Rafuse J. Practical application of air-quality research incorporated in CMHC's research house. CMAJ. 1995;152:1310-1311.
(68) Gray C. Waiting list already 7 months long at Toronto's new Environmental Health Clinic. CMAJ. 1997;156:879-881.
(69) Ontario College of Family Physicians. Taking An Exposure History. http://www.ocfp.on.ca/english/ocfp/communications/publications/default.asp?s=1 . 2005.
(70) Miller CS, Prihoda TJ. The Environmental Exposure and Sensitivity Inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications. Toxicol Ind Health. 1999;15:370-385.
(71) Rea WJ, Didriksen N, Simon TR, Pan Y, Fenyves EJ, Griffiths B. Effects of toxic exposure to molds and mycotoxins in building-related illnesses. Arch Environ Health. 2003;58:399-405.
(72) Joffres MR, Sampalli T, Fox RA. Physiologic and symptomatic responses to low-level substances in individuals with and without chemical sensitivities: a randomized controlled blinded pilot booth study. Environ Health Perspect. 2005;113:1178-1183.
(73) Ashford N, Miller C. Chemical Exposures Low levels and High Stakes. 2nd ed. van Nostrand Reinhold. NY. Nelson Canada; 1998.
(74) Fox RA. The Environment and Multiple Chemical Sensitivity. Nova Scotia Environmental Health Centre, Dalhousie University, Fall River, Nova Scotia,Canada. 2006. Nova Scotia Environmental Health Centre, Dalhousie University, Fall River, Nova Scotia, Canada.
(75) Saijo Y, Kishi R, Sata F et al. Symptoms in relation to chemicals and dampness in newly built dwellings. Int Arch Occup Environ Health. 2004;77:461-470.
(76) Bourbeau J, Brisson C, Allaire S. Prevalence of the sick building syndrome symptoms in office workers before and six months and three years after being exposed to a building with an improved ventilation system. Occup Environ Med. 1997;54:49-53.
(77) Gibson PR, Placek E, Lane J, Brohimer SO, Lovelace AC. Disability-induced identity changes in persons with multiple chemical sensitivity. Qual Health Res. 2005;15:502-524.
(78) Kassirer J and Sandiford K. Socio-Economic Impacts of Environmental Illness
in Canada. 15-11-2000. The Environmental Illness Society of Canada.
(79) Wargocki P, Wyon DP, Sundell J, Clausen G, Fanger PO. The effects of outdoor air supply rate in an office on perceived air quality, sick building syndrome (SBS) symptoms and productivity. Indoor Air. 2000;10:222-236.
(80) Fisk WJ, Rosenfeld AH. Estimates of Improved Productivity and Health from Better Indoor Environments. Indoor Air. 1997;7:158-172.
(81) Hodgson M, Brodt W, Henderson D et al. Needs and opportunities for improving the health, safety, and productivity of medical research facilities. Environ Health Perspect. 2000;108 Suppl 6:1003-8.:1003-1008.
(82) Hedge A, Mitchell GE, McCarthy JF, Ludwig J. Effects of a Furniture-integrated Breathing-zone Filtration System on Indoor Air Quality, Sick Building Syndrome, and Productivity. Indoor Air. 1993;3:328-336.
(83) Wargocki P, Sundell J, Bischof W et al. Ventilation and health in non-industrial indoor environments: report from a European Multidisciplinary Scientific Consensus Meeting (EUROVEN). Indoor Air. 2002;12:113-128.
(84) Bako-Biro Z, Wargocki P, Weschler CJ, Fanger PO. Effects of pollution from personal computers on perceived air quality, SBS symptoms and productivity in offices. Indoor Air. 2004;14:178-187.
(85) Daisey JM, Angell WJ, Apte MG. Indoor air quality, ventilation and health symptoms in schools: an analysis of existing information. Indoor Air. 2003;13:53-64.
(86) Mendell MJ, Heath GA. Do indoor pollutants and thermal conditions in schools influence student performance? A critical review of the literature. Indoor Air. 2005;15:27-52.
(87) Health Canada. Indoor Air Quality - Tools for Schools Action Kit for Canadian Schools. 2003.
(88) Smith RC. The Biopsychosocial Revolution Interviewing and Provider-patient Relationships Becoming Key Issues for Primary Care. J Gen Intern Med 17[4], 309-310. 2002.
(89) Meggs WJ, Elsheik T, Metzger WJ, Albernaz M, Bloch RM. Nasal pathology and ultrastructure in patients with chronic airway inflammation (RADS and RUDS) following an irritant exposure. J Toxicol Clin Toxicol. 1996;34:383-396.
(90) Millqvist E, Ternesten-Hasseus E, Stahl A, Bende M. Changes in levels of nerve growth factor in nasal secretions after capsaicin inhalation in patients with airway symptoms from scents and chemicals. Environ Health Perspect. 2005;113:849-852.
(91) Kimata H. Effect of exposure to volatile organic compounds on plasma levels of neuropeptides, nerve growth factor and histamine in patients with self-reported multiple chemical sensitivity. Int J Hyg Environ Health. 2004;207:159-163.
(92) Interian A, Gara MA, az-Martinez AM et al. The value of pseudoneurological symptoms for assessing psychopathology in primary care. Psychosom Med. 2004;66:141-146.
(93) Ford CV. Somatization and fashionable diagnoses: illness as a way of life. Scand J Work Environ Health. 1997;23 Suppl 3:7-16.:7-16.
(94) Chang C, Gershwin ME. Indoor air quality and human health: truth vs mass hysteria. Clin Rev Allergy Immunol. 2004;27:219-239.
(95) Staudenmayer H, Binkley KE, Leznoff A, Phillips S. Idiopathic environmental intolerance: Part 1: A causation analysis applying Bradford Hill's criteria to the toxicogenic theory. Toxicol Rev. 2003;22:235-246.
(96) Staudenmayer H, Binkley KE, Leznoff A, Phillips S. Idiopathic environmental intolerance: Part 2: A causation analysis applying Bradford Hill's criteria to the psychogenic theory. Toxicol Rev. 2003;22:247-261.
(97) Davidoff AL, Fogarty L. Psychogenic origins of multiple chemical sensitivities syndrome: a critical review of the research literature. Arch Environ Health. 1994;49:316-325.
(98) Leznoff A. Provocative challenges in patients with multiple chemical sensitivity. J Allergy Clin Immunol. 1997;99:438-442.
(99) Leznoff A, Binkley KE. Idiopathic environmental intolerances: results of challenge studies. Occup Med. 2000;15:529-537.
(100) Fiedler N, Kipen HM, DeLuca J, Kelly-McNeil K, Natelson B. A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med. 1996;58:38-49.
(101) Fiedler N. Neuropsychological approaches for the detection and evaluation of toxic symptoms. Environ Health Perspect. 1996;104 Suppl 2:239-45.:239-245.
(102) Fiedler N, Maccia C, Kipen H. Evaluation of chemically sensitive patients. J Occup Med. 1992;34:529-538.
(103) Bornschein S, Hausteiner C, Konrad F, Forstl H, Zilker T. Psychiatric morbidity and toxic burden in patients with environmental illness: a controlled study. Psychosom Med. 2006;68:104-109.
(104) Department of Health and Human Services Centers for Disease Control and Prevention. Third National Report on Human Exposure to Environmental Chemicals. USA Centers for Disease Control and Prevention . 2005.
(105) Baldwin DR and Marshall WJ. Heavy metal poisoning and its laboratory investigation. Ann Clin Biochem 36, 267-300. 1999.
(106) Araki S, Sakai T, Sato H, Kaneko T, Sakai R, Yokoyama K. [Multiple chemical sensitivities: case definition, etiology and relations to allergy, poisoning, psychogenic illness etc]. Nippon Koshu Eisei Zasshi. 1999;46:769-778.
(107) Davidoff AL, Fogarty L, Keyl PM. Psychiatric inferences from data on psychologic/psychiatric symptoms in multiple chemical sensitivities syndrome. Arch Environ Health. 2000;55:165-175.
(108) Poonai NP, Antony MM, Binkley KE et al. Psychological features of subjects with idiopathic environmental intolerance. J Psychosom Res. 2001;51:537-541.
(109) Jason LA, Taylor RR, Kennedy CL. Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. Psychosom Med. 2000;62:655-663.
(110) Aaron LA, Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol. 2003;17:563-574.
(111) Aaron LA, Herrell R, Ashton S et al. Comorbid clinical conditions in chronic fatigue: a co-twin control study. J Gen Intern Med. 2001;16:24-31.
(112) Black DW, Doebbeling BN, Voelker MD et al. Multiple chemical sensitivity syndrome: symptom prevalence and risk factors in a military population. Arch Intern Med. 2000;160:1169-1176.
(113) Beseler C, Stallones L. Safety practices, neurological symptoms, and pesticide poisoning. J Occup Environ Med. 2003;45:1079-1086.
(114) Crago BR, Gray MR, Nelson LA, Davis M, Arnold L, Thrasher JD. Psychological, neuropsychological, and electrocortical effects of mixed mold exposure. Arch Environ Health. 2003;58:452-463.
(115) Stallones L, Beseler C. Pesticide illness, farm practices, and neurological symptoms among farm residents in Colorado. Environ Res. 2002;90:89-97.
(116) Anyanwu E, Campbell AW, Jones J, Ehiri JE, Akpan AI. The neurological significance of abnormal natural killer cell activity in chronic toxigenic mold exposures. ScientificWorldJournal. 2003;3:1128-37.:1128-1137.
(117) Stenn P, Binkley K. Successful outcome in a patient with chemical sensitivity. Treatment with psychological desensitization and selective serotonin reuptake inhibitor. Psychosomatics. 1998;39:547-550.
(118) Schmidt NB, McCreary BT, Trakowski JJ, Santiago HT, Woolaway-Bickel K, Ialongo N. Effects of cognitive behavioral treatment on physical health status in patients with panic disorder. Behavior Therapy. 2003;34:49-63.
(119) Kolk AM, Schagen S, Hanewald GJ. Multiple medically unexplained physical symptoms and health care utilization: outcome of psychological intervention and patient-related predictors of change. J Psychosom Res. 2004;57:379-389.
(120) Saito M, Kumano H, Yoshiuchi K et al. Symptom profile of multiple chemical sensitivity in actual life. Psychosom Med. 2005;67:318-325.
(121) Lacour M, Zunder T, Dettenkofer M, Schonbeck S, Ludtke R, Scheidt C. An interdisciplinary therapeutic approach for dealing with patients attributing chronic fatigue and functional memory disorders to environmental poisoning--a pilot study. Int J Hyg Environ Health. 2002;204:339-346.
(122) Costa LG, Cole TB, Vitalone A, Furlong CE. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clin Chim Acta. 2005;352:37-47.
(123) Infante-Rivard C, Labuda D, Krajinovic M, Sinnett D. Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology. 1999;10:481-487.
(124) Binkley K, King N, Poonai N, Seeman P, Ulpian C, Kennedy J. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7. J Allergy Clin Immunol. 2001;107:887-890.
(125) Miresco MJ, Kirmayer LJ. The persistence of mind-brain dualism in psychiatric reasoning about clinical scenarios. Am J Psychiatry. 2006;163:913-918.
(126) Grammer LC, Harris KE, Cugell DW, Patterson R. Evaluation of a worker with possible formaldehyde-induced asthma. J Allergy Clin Immunol. 1993;92:29-33.
(127) Hasegawa M, Ohtomo M, Mita H, Akiyama K. [Clinical aspects of patients with MCS - from the standpoint of allergy]. Arerugi. 2005;54:478-484.
(128) Campbell AW, Thrasher JD, Madison RA, Vojdani A, Gray MR, Johnson A. Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings. Arch Environ Health. 2003;58:464-474.
(129) Welch DA, Christenson D, Penley L, Chan P, Scoggins P, Shapiro S, Coryell M, Smith W, and O'Grady J. Letter from the National Treasury employees Union to Stephen L. Johnson, Administrator, U.S. Environmental Protection Agency. Public Employees for Environmental Responsibility . 24-5-2006.
(130) Anway MD, Skinner MK. Epigenetic Transgenerational Actions of Endocrine Disruptors. Endocrinology. 2006;147:s43-s49.
(131) Crews D, McLachlan JA. Epigenetics, Evolution, Endocrine Disruption, Health, and Disease. Endocrinology. 2006;147:s4-10.
(132) Cecchini MA, Root DE, Rachunow JR, Gleb PM. Managing Chronic Illness in Patients. Health Status of Rescue Workers Improved by Sauna Detoxification. Townsend Letter The Examiner of Alternative Medicine. 2006.
(133) Schnare DW, Ben M, and Shields MG. Body Burden Reductions of PCBS, PBBs and Chlorinated Pesticides in Human Subjects. AMBIO A journal of the human environment 13, 378-380. 1984.
(134) Younglai EV, Holloway AC, Foster WG. Environmental and occupational factors affecting fertility and IVF success. Hum Reprod Update. 2005;11:43-57.
(135) Younglai EV, Foster WG, Hughes EG, Trim K, Jarrell JF. Levels of environmental contaminants in human follicular fluid, serum, and seminal plasma of couples undergoing in vitro fertilization. Arch Environ Contam Toxicol. 2002;43:121-126.
(136) Swan SH. Semen quality in fertile US men in relation to geographical area and pesticide exposure. Int J Androl. 2006;29:62-68.
(137) Arbuckle TE, Schrader SM, Cole D et al. 2,4-Dichlorophenoxyacetic acid residues in semen of Ontario farmers. Reprod Toxicol. 1999;13:421-429.
(138) Environmental Defence. Toxic Nation A report on pollution in Canadians. Environmental Defence . 2005.
(139) Environmental Defence. Polluted Children Toxic Nation. A report on pollution in Canadian families. Environmental Defence . 2006.
(140) Albertini R, Bird M, Doerrer N et al. The Use of Biomonitoring Data in Exposure and Human Health Risk Assessments. Environ Health Perspect. 2006;114:1755-1762.
(141) Gibson, PR. Understanding & Accommodating People with Multiple Chemical Sensitivity in Independent Living. Independent living Research Utilization at TIRR . 2002.
(142) Gilbert ME. Does the Kindling Model of Epilepsy Contribute to Our Understanding of Multiple Chemical Sensitivity? Annals of the New York Academy of Sciences. 2001;933:68-91.
(143) Bell IR, Baldwin CM, Fernandez M, Schwartz GE. Neural sensitization model for multiple chemical sensitivity: overview of theory and empirical evidence. Toxicol Ind Health. 1999;15:295-304.
(144) Sorg BA, Willis JR, See RE, Hopkins B, Westberg HH. Repeated low-level formaldehyde exposure produces cross-sensitization to cocaine: possible relevance to chemical sensitivity in humans. Neuropsychopharmacology. 1998;18:385-394.
(145) Heuser G, Wu JC. Deep Subcortical (Including Limbic) Hypermetabolism in Patients with Chemical Intolerance: Human PET Studies. Annals of the New York Academy of Sciences. 2001;933:319-322.
(146) Pall ML, Anderson JH. The vanilloid receptor as a putative target of diverse chemicals in multiple chemical sensitivity. Arch Environ Health. 2004;59:363-375.
(147) Pall ML, Satterlee JD. Elevated Nitric Oxide/Peroxynitrite Mechanism for the Common Etiology of Multiple Chemical Sensitivity, Chronic Fatigue Syndrome, and Posttraumatic Stress Disorder. Annals of the New York Academy of Sciences. 2001;933:323-329.
(148) Corrigan FM, MacDonald S, Brown A, Armstrong K, Armstrong EM. Neurasthenic fatigue, chemical sensitivity and GABAa receptor toxins. Med Hypotheses. 1994;43:195-200.
(149) Overstreet DH, Djuric V. A Genetic Rat Model of Cholinergic Hypersensitivity: Implications for Chemical Intolerance, Chronic Fatigue, and Asthma. Annals of the New York Academy of Sciences. 2001;933:92-102.
(150) Pall ML. NMDA sensitization and stimulation by peroxynitrite, nitric oxide, and organic solvents as the mechanism of chemical sensitivity in multiple chemical sensitivity. FASEB J. 2002;16:1407-1417.
(151) Gabriel G. Hans Selye: The Discovery of Stress. BrainConnection . 2006.
(152) Nehlsen-Cannarella S, Fagoaga O, Folz J, Grinde S, Hisey C, Thorpe R. Fighting, fleeing and having fun: the immunology of physical activity. Int J Sports Med. 1997;18 Suppl 1:S8-21.:S8-21.
(153) Hiramoto RN, Rogers CF, Demissie S et al. Psychoneuroendocrine immunology: site of recognition, learning and memory in the immune system and the brain. Int J Neurosci. 1997;92:259-285.
(154) Hiramoto RN, Solvason HB, Hsueh CM et al. Psychoneuroendocrine immunology: perception of stress can alter body temperature and natural killer cell activity. Int J Neurosci. 1999;98:95-129.
(155) Marshall LM, Bested A, Bray RI. Tools to treat Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivity. The Canadian Journal of CME. 2004;56-65.
(156) Ontario College of Family Physicians. Case Criteria Checklists (Chronic Fatigue Syndrome, Fibromyalgia, Mult iple Chemical Sensitivity). OCFP . 2003.
(157) Soden SE and Lowry JA. Provocative urine excretion of heavy metals using meso-2,3-dimercaptosuccinic acid (DMSA) in children with autism. Children's Mercy Hospitals & Clinics (Bridge Grant) . 2006.
(158) Krop JJ. Healing the planet one patient at a time A primer in environmental medicine. Alton ON Canada: KOS Publishing Inc.; 2002.
(159) Bested AC, Logan AC, Howe R. Hope and help for chronic fatigue syndrome and fibromyalgia. Cumberland House Publishing, Nashville, Tennessee, USA; 2006.
(160) Bray R, Coates D, Marshall LM, Rizvi K, and Masson C. Water contaminants: Health effects on children. Children's Health and the Environment: Building capacity for policy development and facilitating policy change, A report to the Canadian Institute for Child Health. 2003. Canadian Institute for Child Health.
(161) Rashid M, Cranney A, Zarkadas M et al. Celiac disease: evaluation of the diagnosis and dietary compliance in Canadian children. Pediatrics. 2005;116:e754-e759.
(162) Accomando S, Cataldo F. The global village of celiac disease. Dig Liver Dis. 2004;36:492-498.
(163) Kitts D, Yuan Y, Joneja J et al. Adverse reactions to food constituents: allergy, intolerance, and autoimmunity. Can J Physiol Pharmacol. 1997;75:241-254.
(164) Logan AC, Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev. 2001;6:450-459.
(165) Chisolm JJ, Jr. Safety and efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) in children with elevated blood lead concentrations. J Toxicol Clin Toxicol. 2000;38:365-375.
(166) National Institutes of Health Clinical Center. An Investigation of the Efficacy of Mercury Chelation as a Treatment for Autism Spectrum Disorder. National Institutes of Health . 2006.
(167) Australian Human Rights and Equal Opportunity Commission. Advisory Notes on Access to Premises. Australian Human Rights and Equal Opportunity Commission . 2006.
(168) State of California - State and Consumer Services Agency. Building Standards Bulletin 2004-01. State of California - State and Consumer Services Agency . 11-4-2004.
(169) National Institute of Building Sciences. IEQ Indoor Environmental Quality. 2005. National Institute of Building Sciences USA.
(170) National Research Council. Canada's Code Development System. National Research Council . 29-1-2002.
(171) Department of Health. Proposed residential indoor air quality guideline for moulds. Canada Gazette. 13-12-2006.
(172) Canadian Construction Association. CCA 82 - Mould Guidelines for the Canadian Construction Industry. 2004.
(173) Ontario Association of Architects. OAA Mould Control Practice Guide. Ontario Architects' Association . 2003.
(174) World Health Organization Regional Office for Europe Copenhagen. Air Quality Guidelines for Europe . WHO Regional Publications, European Series, No.91 [Second Edition]. 2006.
(175) Won, D., Magee, R. J., Yang, W., Lusztyk, E., Nong, G., and Shaw, C. Y. A Material emission database for 90 target VOCs. National Research Council Canada . 2005.
(176) Shaw, C. Y., Won, D., and Reardon, J. Managing Volatile Organic Compounds and Indoor Air Quality in Office Buildings – An Engineering Approach. RR-205. 2005.
(177) Apte MG, Fisk WJ, Daisey JM. Associations between indoor CO2 concentrations and sick building syndrome symptoms in U.S. office buildings: an analysis of the 1994-1996 BASE study data. Indoor Air. 2000;10:246-257.
(178) Won, D., Lusztyk, E., and Shaw, C. Y. Target VOC List. National Research Council Canada . 2005.
(179) Environment Canada. The Need for Immediate Action - Canada's New Clean Air Regulatory Agenda - Backgrounder. The Green LaneTM, Environment Canada's World Wide Web site . 19-10-2006.
(180) Lindblad-Toh K. Genome sequencing Three's company. Nature. 2004;428:475-476.
(181) ASHRAE Board of Directors. Indoor Air Quality. American Society of Healthing, Refrigerating and Air-Conditioning Engineers, Inc.1791 Tullie Circle, NE • Atlanta, Georgia 30329-2305 • (404) 636-8400 • fax: (404) 321-5478. 10-2-2005.
(182) Kilburn KH. Indoor air effects after building renovation and in manufactured homes. Am J Med Sci. 2000;320:249-254.
(183) Reitzig M, Mohr S, Heinzow B, Knoppel H. VOC Emissions after Building Renovations: Traditional and Less Common Indoor Air Contaminants, Potential Sources, and Reported Health Complaints. Indoor Air. 1998;8:91-102.
(184) Canada Green Building Council. Green Building Rating System for New Construction & Major Renovations LEED Canada-NC Version 1.0. Canada Green Building Council . 2004.
(185) Yura A, Iki M, Shimizu T. [Indoor air pollution in newly built or renovated elementary schools and its effects on health in children]. Nippon Koshu Eisei Zasshi. 2005;52:715-726.
(186) Molhave L, Dueholm S, Jensen LK. Assessment of Exposures and Health Risks Related to Formaldehyde Emissions from Furniture: a Case Study. Indoor Air. 1995;5:104-119.
(187) Greenpeace. Guide to Greener Electronics. 18-9-2006.
(188) Bridges B. Fragrances and allergic reactions. J Am Board Fam Pract. 2001;14:400a-4401.
(189) Bridges B. Fragrance: emerging health and environmental concerns. Flavour Fragr J 17, 361-371. 2002. 17-1-2007.
(190) Anderson RC, Anderson JH. Acute toxic effects of fragrance products. Arch Environ Health. 1998;53:138-146.
(191) Lessenger JE. Occupational acute anaphylactic reaction to assault by perfume spray in the face. J Am Board Fam Pract. 2001;14:137-140.
(192) Public Service Alliance of Canada. PSAC Awareness kit on scent-free environments (Chemical Sensitivities - Environmental Illness). PSAC . 1998.
(193) Small BM. Creating mold-free buildings: a key to avoiding health effects of indoor molds. Arch Environ Health. 2003;58:523-527.
(194) Lee TG. Health symptoms caused by molds in a courthouse. Arch Environ Health. 2003;58:442-446.
(195) Shoemaker RC, House DE. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms. Neurotoxicol Teratol. 2006;28:573-588.
(196) Edmondson DA, Nordness ME, Zacharisen MC, Kurup VP, Fink JN. Allergy and "toxic mold syndrome". Ann Allergy Asthma Immunol. 2005;94:234-239.
(197) Vojdani A, Campbell AW, Kashanian A, Vojdani E. Antibodies against molds and mycotoxins following exposure to toxigenic fungi in a water-damaged building. Arch Environ Health. 2003;58:324-336.
(198) Meyer HW, Wurtz H, Suadicani P, Valbjorn O, Sigsgaard T, Gyntelberg F. Molds in floor dust and building-related symptoms in adolescent school children. Indoor Air. 2004;14:65-72.
(199) Meyer HW, Wurtz H, Suadicani P, Valbjorn O, Sigsgaard T, Gyntelberg F. Molds in floor dust and building-related symptoms among adolescent school children: a problem for boys only? Indoor Air. 2005;15 Suppl 10:17-24.:17-24.
(200) Meklin T, Husman T, Vepsalainen A et al. Indoor air microbes and respiratory symptoms of children in moisture damaged and reference schools. Indoor Air. 2002;12:175-183.
(201) Straus DC, Cooley JD, Wong WC, Jumper CA. Studies on the role of fungi in Sick Building Syndrome. Arch Environ Health. 2003;58:475-478.
(202) Ahman M, Lundin A, Musabasic V, Soderman E. Improved Health After Intervention in a School with Moisture Problems. Indoor Air. 2000;10:57-62.
(203) Ebbehoj NE, Hansen MO, Sigsgaard T, Larsen L. Building-related symptoms and molds: a two-step intervention study. Indoor Air. 2002;12:273-277.
(204) Centers for Disease Control.U.S.Department of Health and Human Services. Respiratory Infection - Pennsylvania. Morbidity and Mortality Weekly Report. 1997;46:49-56.
(205) Hirvonen M-R, Huttunen K, Roponen M. Bacterial strains from moldy buildings are highly potent inducers of inflammatory and cytotoxic effects. Indoor Air. 2005;15:65-70.
(206) Warsco K, Lindsey PF. Proactive approaches for mold-free interior environments. Arch Environ Health. 2003;58:512-522.
(207) Brandt M, Brown C, Burkhart J, Burton N, Cox-Ganser J, Damon S, Falk H, Fridkin S, Garbe P, McGeehin M, Morgan J, Page E, Rao C, Redd S, Sinks T, Trout D, Wallingford K, Warnock D, and Weissman D. Mold Prevention Strategies and Possible Health Effects in the Aftermath of Hurricanes and Major Floods. Morbidity and Mortality Weekly Report 55[RR08], 1-27. 2006. Centers for Disease Control. USA.
(208) Shusterman D, Balmes J, Avila PC, Murphy MA, Matovinovic E. Chlorine inhalation produces nasal congestion in allergic rhinitics without mast cell degranulation. Eur Respir J. 2003;21:652-657.
(209) Gorguner M, Aslan S, Inandi T, Cakir Z. Reactive airways dysfunction syndrome in housewives due to a bleach-hydrochloric acid mixture. Inhal Toxicol. 2004;16:87-91.
(210) Shusterman D, Murphy MA, Walsh P, Balmes JR. Cholinergic blockade does not alter the nasal congestive response to irritant provocation. Rhinology. 2002;40:141-146.
(211) Thickett KM, McCoach JS, Gerber JM, Sadhra S, Burge PS. Occupational asthma caused by chloramines in indoor swimming-pool air. Eur Respir J. 2002;19:827-832.
(212) Medina-Ramon M, Zock JP, Kogevinas M et al. Asthma, chronic bronchitis, and exposure to irritant agents in occupational domestic cleaning: a nested case-control study. Occup Environ Med. 2005;62:598-606.
(213) U.S.Environmental Protection Agency Office of Air and Radiation Indoor Environments Division. Mold Remediation in Schools and Commercial Buildings. US EPA . 2007.
(214) Common Ground Collective. EM used to clean up mold. Common Ground Relief . 11-11-2006.
(215) Seppanen OA, Fisk WJ. Summary of human responses to ventilation. Indoor Air. 2004;14:102-118.
(216) Sherman M. ASHRAE's New Residential Ventilation Standard. ASHRAE Journal, January 2004. 2004.
(217) Bourbeau J, Brisson C, Allaire S. Prevalence of the sick building syndrome symptoms in office workers before and after being exposed to a building with an improved ventilation system. Occup Environ Med. 1996;53:204-210.
(218) Wargocki P, Lagercrantz L, Witterseh T, Sundell J, Wyon DP, Fanger PO. Subjective perceptions, symptom intensity and performance: a comparison of two independent studies, both changing similarly the pollution load in an office. Indoor Air. 2002;12:74-80.
(219) Abraham ME. Microanalysis of Indoor Aerosols and the Impact of a Compact High-Efficiency Particulate Air (HEPA) Filter System. Indoor Air. 1999;9:33-40.
(220) Moritz M, Peters H, Nipko B, Ruden H. Capability of air filters to retain airborne bacteria and molds in heating, ventilating and air-conditioning (HVAC) systems. Int J Hyg Environ Health. 2001;203:401-409.
(221) Clausen G. Ventilation filters and indoor air quality: a review of research from the International Centre for Indoor Environment and Energy. Indoor Air. 2004;14:202-207.
(222) Tarkowski M, Lutz W, Birindelli S. The lymphocytic cholinergic system and its modulation by organophosphorus pesticides. Int J Occup Med Environ Health. 2004;17:325-337.
(223) Sandborn M, Cole D, Kerr K, Vakil C, Sanin LH, and Bassil K. Ontario College of Family Physicians. Pesticides Literature Review. 2003. 27-8-2006.
(224) National Institute of Environmental Health Sciences. Questions and Answers - EMF in the Workplace. 1996.
(225) Havas M. Biological effects of non-ionizing electromagnetic energy: A critical review of the reports by the US National Research Council and the US National Institute of Environmental Health Sciences as they relate to the broad realm of EMF bioeffects. Environ Rev. 2000;8:173-253.
(226) Kheifets L, Repacholi M, Saunders R, van DE. The sensitivity of children to electromagnetic fields. Pediatrics. 2005;116:e303-e313.
(227) Goldsmith JR. Epidemiologic evidence relevant to radar (microwave) effects. Environ Health Perspect. 1997;105 Suppl 6:1579-87.:1579-1587.
(228) Hocking B. Microwave sickness: a reappraisal. Occup Med (Lond). 2001;51:66-69.
(229) Hocking B. Mobile phone use and risk of acoustic neuroma. Br J Cancer. 2006;94:1350-1353.
(230) Hocking B, Westerman R. Neurological effects of radiofrequency radiation. Occup Med (Lond). 2003;53:123-127.
(231) Kundi M. Re: "cellular telephone use and risk of acoustic neuroma". Am J Epidemiol. 2004;160:923-924.
(232) Schuz J, Bohler E, Berg G et al. Cellular phones, cordless phones, and the risks of glioma and meningioma (Interphone Study Group, Germany). Am J Epidemiol. 2006;163:512-520.
(233) Hardell L, Hansson MK. Mobile phone use and risk of acoustic neuroma: results of the interphone case-control study in five North European countries. Br J Cancer. 2006;94:1348-1349.
(234) Hardell L, Hansson MK, Sandstrom M, Carlberg M, Hallquist A, Pahlson A. Vestibular schwannoma, tinnitus and cellular telephones. Neuroepidemiology. 2003;22:124-129.
(235) Hardell L, Mild KH, Carlberg M. Further aspects on cellular and cordless telephones and brain tumours. Int J Oncol. 2003;22:399-407.
(236) Hardell L, Mild KH, Carlberg M, Hallquist A. Cellular and cordless telephone use and the association with brain tumors in different age groups. Arch Environ Health. 2004;59:132-137.
(237) Hardell L, Carlberg M, Mild KH. Case-control study of the association between the use of cellular and cordless telephones and malignant brain tumors diagnosed during 2000-2003. Environ Res. 2006;100:232-241.
(238) Institute of Biomedical Engineering Technology. Electromagnetic Interference: Causes and Concerns in the Health Care Environment. IBET is administered by the Applied Science Technologists and Technicians of British Columbia (ASTTBC) All professional Biomedical Engineering Technologists and Technicians registered with the ASTTBC are members of IBET. 2007.
(239) World Health Organization. 2006 WHO Research Agenda for Radio Frequency Fields. World Health Organization . 2006.
(240) Maisch D, Podd J, and Rapley B. Changes in Health Status in a Group of CFS and CF Patients Following Removal of Excessive 50 Hz Magnetic Field Exposure. Journal of Australian College of Nutritional & Environmental Medicine 21[1], 15-19. 2002.
(241) Arendt J. Melatonin and human rhythms. Chronobiol Int. 2006;23:21-37.
(242) Roberts JE. Update on the positive effects of light in humans. Photochem Photobiol. 2005;81:490-492.
(243) Kauppila A, Pakarinen A, Kirkinen P, Makila U. The effect of season on the circulating concentrations of anterior pituitary, ovarian and adrenal cortex hormones and hormone binding proteins in the subarctic area; evidence of increased activity of the pituitary-ovarian axis in spring. Gynecol Endocrinol. 1987;1:137-150.
(244) Rea MS, Figueiro MG, Bullough JD, Bierman A. A model of phototransduction by the human circadian system. Brain Res Brain Res Rev. 2005;50:213-228.
(245) Genuis SJ. Keeping your sunny side up. How sunlight affects health and well-being. Can Fam Physician. 2006;52:422-3, 429-31.:422-431.
(246) Kuller R, Laike T. The impact of flicker from fluorescent lighting on well-being, performance and physiological arousal. Ergonomics. 1998;41:433-447.
(247) Marks TA, Ratke CC, English WO. Stray voltage and developmental, reproductive and other toxicology problems in dogs, cats and cows: a discussion. Vet Hum Toxicol. 1995;37:163-172.
(248) Hultgren J. Small electric currents affecting farm animals and man: a review with special reference to stray voltage. I. Electric properties of the body and the problem of stray voltage. Vet Res Commun. 1990;14:287-298.
(249) Hultgren J. Small electric currents affecting farm animals and man: a review with special reference to stray voltage. II. Physiological effects and the concept of stress. Vet Res Commun. 1990;14:299-308.
(250) Mairs RJ, Hughes K, Fitzsimmons S et al. Microsatellite analysis for determination of the mutagenicity of extremely low-frequency electromagnetic fields and ionising radiation in vitro. Mutat Res. 2007;626:34-41.
(251) Mild KH, Mattsso MO, Hardell L, Bowman JD, Kundi M. Occupational carcinogens: ELF MFs. Environ Health Perspect. 2005;113:A726-A727.
(252) de VF, van DH, Engels H, Kromhout H. Exposure, health complaints and cognitive performance among employees of an MRI scanners manufacturing department. J Magn Reson Imaging. 2006;23:197-204.
(253) Hardell L, Mild KH, Carlberg M, Soderqvist F. Tumour risk associated with use of cellular telephones or cordless desktop telephones. World J Surg Oncol. 2006;4:74.:74.
(254) Schoemaker MJ, Swerdlow AJ, Ahlbom A et al. Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five North European countries. Br J Cancer. 2005;93:842-848.
(255) Maisch D. Mobile Phone Use: it's time to take precautions. Journal of Australasian College of Nutritional & Environmentl Medicine. 2002;21:3-10.
(256) International Association of Fire Fighters and Division of Occupational Health, Safety and Medicine. Position on the Health Effects from Radio Frequency/Microwave (RF/MW) Radiation in Fire Department Facilities from Base Stations for Antennas and Towers for the Conduction of Cell Phone Transmissions. 2006.
(257) Boyd DR. The Food We Eat. David Suzuki Foundation . 2006.
(258) Indoor Environments Division Office of Radiation and Indoor Air Office of Air and Radiation United States Environmental Protection Agency. Energy Cost and IAQ Performance of Ventilation Systems and Controls - Project Report # 7 The Cost of Protecting Indoor Environmental Quality During Energy Efficiency Projects for Office and Education Buildings - Integrating Indoor Environmental Quality with Energy Efficiency. USA Environmental Protection Agency . 2000.
(259) New Zealand Association of Hairdressers Inc. Guide to occupational safety and health for the hairdressing industry. 1997.
(260) Connecticut Department of Public Health - Division of Environmental Epidemiology & Occupational Health. Hairdressers and Work-related Respiratory Disease. 1998.
(261) Bowman JK, Kelsh MA, and Kaune WT. Manual for Measuring Occupational Electric and Magnetic Field Exposures. NIOSH . 1998.
(262) Kats G. Greening America's Schools Costs and Benefits. www.cap-e.com . 2006.
(263) Environmental Law Institute. Building Healthy, High Performance Schools: A Review of Selected State and Local Initiatives. Washington D.C.All rights reserved.ISBN# 1-58576-069-2, ELI project code 011404 . 2003.
(264) Pejtersen J, Brohus H, Hyldgaard CE et al. Effect of renovating an office building on occupants' comfort and health. Indoor Air. 2001;11:10-25.
(265) Chao HJ, Schwartz J, Milton DK, Burge HA. The work environment and workers' health in four large office buildings. Environ Health Perspect. 2003;111:1242-1248.
(266) WHO European Centre for Environment and Health. Strategic approaches to indoor air policy-making. World Health Organization . 1999.